Zentek partners with RSK to market air filters globally

GUELPH, ON - Zentek Ltd. (NASDAQ:ZTEK)(TSXV:ZEN), a technology firm specializing in the development of advanced filtration products, has announced a new partnership with RSK Environment Ltd., a UK-based environmental consultancy. The agreement, signed on May 7, 2025, appoints RSK as the authorized agent for Zentek’s ZenGUARD™ Enhanced Air Filters in over 20 countries. The company, currently valued at $157.21 million, has shown strong momentum with a 27% gain over the past six months, according to InvestingPro data.

The collaboration is set to bolster Zentek’s international presence, particularly in the Gulf Cooperation Council (GCC) region, by leveraging RSK’s expertise in environmental and technical services to identify and develop sales opportunities. Zentek will maintain control over manufacturing and fulfillment processes, while RSK will receive a fixed commission on sales within the designated territories. The partnership is established for an initial term of three years with options to renew.

Greg Fenton, CEO of Zentek, expressed enthusiasm about the partnership, citing RSK’s global leadership in environmental solutions as a key factor in accelerating the adoption of ZenGUARD™ Enhanced Air Filters. These filters are designed to improve indoor air quality and energy efficiency, aligning with increasing global demands for sustainable infrastructure solutions.

Ian Goodacre, Director at RSK, also commented on the partnership, emphasizing the growing need among their clients for sustainable options that are both effective and easy to implement. He indicated that ZenGUARD™ Enhanced Air Filters could meet these needs by enhancing air quality and reducing energy consumption.

This agreement complements Zentek’s existing collaborations, including those with Saudi-based Filtration Solutions Industrial Co. and Levidian, aimed at expanding the reach of ZenGUARD™ and other graphene-enhanced products in the GCC region.

Zentek is an ISO 13485:2016 certified company with a focus on creating innovative products that enhance the performance and environmental impact of its partners’ offerings. Its patented ZenGUARD™ technology has shown significant improvements in bacterial and viral filtration efficiency for surgical masks and aims to replicate this performance in HVAC systems.

This strategic partnership is poised to further Zentek’s international sales initiatives, aligning advanced HVAC filtration technology with regional sustainability goals. While the company maintains moderate debt levels and faces profitability challenges, InvestingPro analysis reveals 10+ additional insights about Zentek’s financial health and growth prospects. The information in this article is based on a press release statement from Zentek Ltd. Subscribers to InvestingPro can access detailed financial metrics, Fair Value estimates, and comprehensive analysis to better evaluate this emerging player in the filtration technology sector.

In other recent news, Zentek Ltd. has announced several key developments. The company reported that its ZenGUARD™ Enhanced Air Filters have maintained their viral filtration efficiency after 20 months of aging, as verified by LMS Technologies, Inc. This finding supports Zentek’s plans to market the filters as a Class I medical device, with a 20-month expiry date. Additionally, Zentek has secured an order for these filters from the Forensic Services and Coroner’s Complex in Toronto, managed by Dexterra Group Inc., indicating a growing interest in their technology within the Canadian market.

In another development, Zentek has advanced its avian influenza countermeasure to the testing phase, supported by a CAD 1.1 million project from Canada’s Innovative Solutions Canada Testing Stream. The project aims to develop a prophylactic and therapeutic solution for the avian influenza A(H5N1). Zentek’s collaboration with McMaster University has shown promising results, with the lead candidate matching the neutralization performance of a monoclonal antibody control.

These recent advancements highlight Zentek’s ongoing efforts in technology development and commercialization. The company continues to work on enhancing its ZenGUARD™ technology for various applications, including HVAC systems and surgical masks. CEO Greg Fenton expressed confidence in the company’s progress towards commercialization, emphasizing the effectiveness and safety of their air filtration solutions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.